ArticleFrontiers in microbiology2018
New Delhi Metallo-Beta-Lactamase-Producing Enterobacteriaceae in South Korea Between 2010 and 2015.
Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.
- Emergence and rapid global dissemination of CTX-M-15-associated Klebsiella pneumoniae strain ST307.The Journal of antimicrobial chemotherapy · 2019Pooled it
- Beyond β-Lactams: Defining the Role of Eravacycline in Multidrug-Resistant and Metallo-β-Lactamase-Producing Infections.Antibiotics (Basel, Switzerland) · 2026Review
- Molecular epidemiology and population structure ofMicrobiology spectrum · 2026Article
- Characterization of NDM-4-ProducingInfection and drug resistance · 2026Article
- Nationwide Burden of Metallo-β-Lactamase Genes in Brazilian ClinicalAntibiotics (Basel, Switzerland) · 2025Review
- Complete-genome sequencing and comparative genomic characterization of blaBMC genomics · 2023Article
- Diversity and Distribution ofAntibiotics (Basel, Switzerland) · 2023Article
- First report of coexistence ofFrontiers in microbiology · 2023Article
- Whole genome sequence analysis of ESBL-producingMicrobial genomics · 2022Article
- Comparative genomic analysis of plasmids encoding metallo-β-lactamase NDM-5 in Enterobacterales Korean isolates from companion dogs.Scientific reports · 2022Article
- Genetic Characterization ofInfection and drug resistance · 2022Article
- ISmSystems · 2021Article
- Identification and infection control of carbapenem-resistant Enterobacterales in intensive care units.Acute and critical care · 2021Article
- Molecular characteristics of antibiotic-resistant Escherichia coli and Klebsiella pneumoniae strains isolated from hospitalized patients in Tehran, Iran.Annals of clinical microbiology and antimicrobials · 2021Article
- Comparison of Extended-Spectrum Beta-Lactamase-ProducingFrontiers in microbiology · 2021Article
- Carbapenem-ResistantInfection and drug resistance · 2021Article
- Clinical and Genomic Epidemiology of Carbapenem-NonsusceptibleJournal of clinical microbiology · 2020Article
- Emergence and transmission of New Delhi metallo-beta-lactamase-5-producing Escherichia coli Sequence Type 361 in a Tertiary Hospital in South Korea.Journal of clinical laboratory analysis · 2020Article
- Comparison of ertapenem non-susceptibility with 2-mercaptopropionic acid phenotypic tests in predicting NDM-1 and IMP-1 production in clinical isolates of Escherichia coli.Caspian journal of internal medicine · 2020Article
- First report of a blaNDM-resistant gene in a Klebsiella aerogenes clinical isolate from Brazil.Revista da Sociedade Brasileira de Medicina Tropical · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study was carried out to investigate the epidemiological time-course of New Delhi metallo-beta-lactamase- (NDM-) mediated carbapenem resistance in Enterobacteriaceae in South Korea. A total of 146 non-duplicate NDM-producing Enterobacteriaceae recovered between 2010 and 2015 were voluntarily collected from 33 general hospitals and confirmed by PCR. The species were identified by sequences of the 16S rDNA. Antimicrobial susceptibility was determined either by the disk diffusion method or by broth microdilution, and the carbapenem MICs were determined by agar dilution. Then, multilocus sequence typing and PCR-based replicon typing was carried out. Co-carried genes for drug resistance were identified by PCR and sequencing. The entire genomes of eight random selected NDM producers were sequenced. A total of 69
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.